Jul 26, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
It’s no lie the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate...
Jun 15, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Enhancing Drug Bioavailability and Solubility Approximately 40% of drugs on the market place and a high percentage of APIs in development are poorly soluble. Optimization of drug solubility and BA of therapeutics stands as one of the top challenges faced by the...
Recent Comments